Medical devices, healthcare technology and the business of care
510(k) clearance · K261287

Digistat Care

Ascom Ums Srl Unipersonale · Decision date Sep 12, 2026

MEDTECHLEDGER EXPLANATIONK261287

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Digistat Care, submitted by Ascom Ums Srl Unipersonale of Scandicci, Italy, under 510(k) number K261287. The decision date is September 12, 2026, and the application was received April 20, 2026. The device is listed under regulation 870.2300, classification name System, Network and Communication, Physiological Monitors, with primary product code MSX and subsequent product code PHC; the regulation medical specialty and review panel are both Cardiovascular. SESE in this context is a 510(k) clearance, not a premarket approval.

The reviewed document describes Digistat Care as software that transfers, stores, elaborates, organizes and displays patient information, generates alarm signals for user notification based on signals determined and sent by compatible medical devices, and exchanges information with systems not associated with active patient monitoring. It is intended for trained healthcare professionals in professional healthcare facilities and not for home use. The public record notes a traditional summary, no third-party review, no combination product, and no authorized predetermined change control plan.

The record does not identify a predicate device, the specific cleared modifications, or performance data supporting the clearance, and no clinical or efficacy conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 12, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261287
Regulatory pathway
510(k) premarket notification
Product code
MSX
Decision code
SESE
Decision date
Sep 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Network And Communication, Physiological Monitors.

Product code
MSX
FDA device class
2

FDA decision timeline

  1. K261287 received

    Application receipt date recorded by FDA.

  2. K261287 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MSX

Product / regulatory recordCompanyPathwayDecision dateSource
eClinicsK260075
Ceiba Healthcare US, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ascom Ums Srl Unipersonale

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Scandicci (Fi)

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records